Peter McArdle
Impact in
- Oncology top 5%
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
Papers in
- Oncology 13
- Inflammatory Biomarkers in Disease Prognosis 9
- Cancer Immunotherapy and Biomarkers 4
-
- Prostate Cancer Treatment and Research 5
- Renal cell carcinoma treatment 4
- Co-authors
- Donald C. McMillan (10 shared papers)Khalid Canna (3 shared papers)A. M. McNicol (3 shared papers)C S McArdle (1 shared paper)Ruth F. McKee (1 shared paper)Michael Aitchison (3 shared papers)Mark A. Underwood (6 shared papers)Tahir Qayyum (9 shared papers)
- Journals
- British Journal of Cancer (6 papers)SpringerPlus (1 paper)Australasian Journal on Ageing (1 paper)Cancer Biomarkers (1 paper)Human Pathology (1 paper)
- Partner nations
- United KingdomAustraliaUnited States
In The Last Decade
Peter McArdle
25 papers receiving 866 citations
Peers
Comparison fields: 5 of 83
- Oncology 518
- Cancer Research 227
- Psychiatry and Mental health 120
- Immunology 159
- Pulmonary and Respiratory Medicine 246
Countries citing papers authored by Peter McArdle
This map shows the geographic impact of Peter McArdle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter McArdle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter McArdle more than expected).
Fields of papers citing papers by Peter McArdle
This network shows the impact of papers produced by Peter McArdle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter McArdle. The network helps show where Peter McArdle may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter McArdle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 196 | |
| 2 | 2003 | 133 | |
| 3 | 2017 | 97 | |
| 4 | 2004 | 91 | |
| 5 | 2006 | 65 | |
| 6 | 2008 | 43 | |
| 7 | 2005 | 31 | |
| 8 | 2004 | 31 | |
| 9 | 2012 | 30 | |
| 10 | 2010 | 28 | |
| 11 | 2012 | 27 | |
| 12 | 1997 | 17 | |
| 13 | 2012 | 15 | |
| 14 | 2012 | 15 | |
| 15 | 2013 | 13 | |
| 16 | 2012 | 11 | |
| 17 | 2013 | 9 | |
| 18 | 2016 | 7 | |
| 19 | 2008 | 6 | |
| 20 | 2011 | 4 |
About Peter McArdle
Peter McArdle is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Psychiatry and Mental health, having authored 26 papers that have together received 879 indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (9 papers), Cancer, Lipids, and Metabolism (7 papers), Prostate Cancer Treatment and Research (5 papers), Renal cell carcinoma treatment (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Renal and related cancers (3 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Schizophrenia research and treatment (3 papers). The work is most often cited by research in Oncology (518 citations), Cancer Research (227 citations), Psychiatry and Mental health (120 citations), Immunology (159 citations) and Pulmonary and Respiratory Medicine (246 citations). Peter McArdle has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Donald C. McMillan, Khalid Canna, A. M. McNicol, C S McArdle, Ruth F. McKee, Michael Aitchison, Mark A. Underwood, Tahir Qayyum, E. Bromwich and Michaela Brown. Their work appears in journals such as British Journal of Cancer, SpringerPlus, Australasian Journal on Ageing, Cancer Biomarkers and Human Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.